Top Pharmaceuticals Companies & Activities Reviewed in New GlobalData Study Now Available at MarketPublishers.com
30 Jul 2012 • by Natalie Aster
LONDON – New report "Pharmaceutical Leaders 2012 - Key Trends, Emerging Strategies and Financial Analysis of the Top Performers" provided by GlobalData covers a deep research of top players in the pharmaceutical industry and an analysis and ranking methodology to reveal top performers, industry trends, and the strategies that successful companies are using to stay ahead in the increasingly demanding pharmaceutical marketplace.
The report features major drug approvals and significant M&A and license agreements, as well as other significant cost-containment and operations strategies.
In detail the report includes:
- full financial details and for the top 25 pharmaceutical companies including detailed analysis of key performance metrics;
- analysis of the key drivers, trends, and strategies employed by leading companies across important geographic regions including the US, EU, Japan, Asia-Pacific, Brazil, Russia, India, China, and other emerging markets;
- in addition to the six major therapy areas of cardiovascular disease, central nervous system (CNS), diabetes and metabolic, immunology, oncology, and respiratory diseases, the report analyzes the leading players in the generic pharmaceuticals market;
- analysis of important events in 2010 and 2011 that drove the success of leading companies during the year.
Pharmaceutical Leaders 2012 - Key Trends, Emerging Strategies and Financial Analysis of the Top Performers
Published: July, 2012
Price: US$ 5.700,00
More new market research reports by the publisher can be found at GlobalData page.